Compounds > 4-(n-maleimido)benzyltrimethylammonium
Page last updated: 2024-09-04

4-(n-maleimido)benzyltrimethylammonium and (2-(trimethylammonium)ethyl)methanethiosulfonate

4-(n-maleimido)benzyltrimethylammonium has been researched along with (2-(trimethylammonium)ethyl)methanethiosulfonate in 1 studies

Compound Research Comparison

Studies
(4-(n-maleimido)benzyltrimethylammonium)		Trials
(4-(n-maleimido)benzyltrimethylammonium)		Recent Studies (post-2010)
(4-(n-maleimido)benzyltrimethylammonium)		Studies
((2-(trimethylammonium)ethyl)methanethiosulfonate)		Trials
((2-(trimethylammonium)ethyl)methanethiosulfonate)		Recent Studies (post-2010) ((2-(trimethylammonium)ethyl)methanethiosulfonate)
1902143017

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, JB; Sullivan, DA1

Other Studies

1 other study(ies) available for 4-(n-maleimido)benzyltrimethylammonium and (2-(trimethylammonium)ethyl)methanethiosulfonate

ArticleYear
Mapping the agonist binding site of the nicotinic acetylcholine receptor. Orientation requirements for activation by covalent agonist.
    The Journal of biological chemistry, 2000, Apr-28, Volume: 275, Issue:17

    Topics: Acetylcholine; Affinity Labels; Alkylation; Animals; Binding Sites; Cysteine; Dose-Response Relationship, Drug; Ethyl Methanesulfonate; Indicators and Reagents; Kinetics; Mesylates; Models, Chemical; Mutagenesis; Nicotinic Agonists; Patch-Clamp Techniques; Protein Structure, Quaternary; Quaternary Ammonium Compounds; Receptors, Nicotinic; Time Factors; Transcription, Genetic; Xenopus

2000